Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Condylomata Acuminata × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 837 Neoplasms 643 Carcinoma, Non-Small-Cell Lung 630 Prostatic Neoplasms 511 Colorectal Neoplasms 413 Lung Neoplasms 377 Neoplasm Metastasis 325 Multiple Myeloma 305 Leukemia, Myeloid, Acute 300 Ovarian Neoplasms 279 Melanoma 252 Squamous Cell Carcinoma of Head and Neck 226 Pancreatic Neoplasms 220 Recurrence 206 Brain Neoplasms 185 Glioblastoma 180 Stomach Neoplasms 174 Triple Negative Breast Neoplasms 173 Carcinoma, Hepatocellular 172 Endometrial Neoplasms 168 Uterine Cervical Neoplasms 166 Lymphoma 163 Precursor Cell Lymphoblastic Leukemia-Lymphoma 157 Head and Neck Neoplasms 154 Carcinoma, Renal Cell 151 Urinary Bladder Neoplasms 142 Leukemia, Lymphocytic, Chronic, B-Cell 138 Lymphoma, Non-Hodgkin 135 Glioma 131 Lymphoma, Large B-Cell, Diffuse 130

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hepatitis B Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02750202 2026-01-23

TheraVACCS

University of Pretoria

Phase 3 Completed

52 enrolled 34 charts

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon ⚡